Home › Funds › Principal Global Investors › CLOV
Principal Global Investors position in CLOV
CLOVER HEALTH INVESTMENTS CO · Health Care
Latest position (Q2 2026)32.16K sh
Reported value held$168.54K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 18.02K | $133.00K | New |
| Q4 2021 | 28.23K | $105.00K | Add |
| Q1 2022 | 26.73K | $95.00K | Reduce |
| Q2 2022 | 101.70K | $218.00K | Add |
| Q3 2022 | 99.33K | $168.00K | Reduce |
| Q4 2022 | 46.72K | $43.43K | Reduce |
| Q1 2023 | 42.82K | $36.19K | Reduce |
| Q2 2025 | 28.72K | $80.12K | New |
| Q3 2025 | 485.43K | $1.49M | Add |
| Q4 2025 | 709.48K | $1.67M | Add |
| Q1 2026 | 30.12K | $53.02K | Reduce |
| Q2 2026 | 32.16K | $168.54K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CLOV
- BlackRock Inc 35.11M sh · $183.96M · Q2 2026
- Geode Capital Management 10.85M sh · $56.84M · Q2 2026
- Vanguard Group 23.49M sh · $55.19M · Q4 2025
- Charles Schwab Investment Management 5.52M sh · $28.93M · Q2 2026
- Northern Trust Corp 3.77M sh · $19.77M · Q2 2026
- PNC Financial Services 3.56M sh · $18.67M · Q2 2026
- Renaissance Technologies 2.81M sh · $14.71M · Q2 2026
- Morgan Stanley 2.29M sh · $12.02M · Q2 2026
- D. E. Shaw & Co 1.97M sh · $10.30M · Q2 2026
- Marshall Wace 1.56M sh · $8.19M · Q2 2026
- Invesco Ltd 1.34M sh · $7.00M · Q2 2026
- BNY Mellon 1.21M sh · $6.35M · Q2 2026